0001246360-14-004791.txt : 20141230
0001246360-14-004791.hdr.sgml : 20141230
20141230164909
ACCESSION NUMBER: 0001246360-14-004791
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141229
FILED AS OF DATE: 20141230
DATE AS OF CHANGE: 20141230
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNAGEVA BIOPHARMA CORP
CENTRAL INDEX KEY: 0000911326
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 561808663
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 33 HAYDEN AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: (781) 357-9900
MAIL ADDRESS:
STREET 1: 33 HAYDEN AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: TRIMERIS INC
DATE OF NAME CHANGE: 19970516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heberlig Chris
CENTRAL INDEX KEY: 0001532217
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23155
FILM NUMBER: 141316461
MAIL ADDRESS:
STREET 1: 128 SPRING STREET, SUITE 520
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
form.xml
PRIMARY DOCUMENT
X0306
4
2014-12-29
false
0000911326
SYNAGEVA BIOPHARMA CORP
GEVA
0001532217
Heberlig Chris
33 HAYDEN AVE
LEXINGTON
MA
02421
false
true
false
false
Group Vice President, Finance
Common Stock
2014-12-29
4
M
false
1100
1.7
A
1404
D
Common Stock
2014-12-29
4
M
false
5000
23
A
6404
D
Common Stock
2014-12-29
4
S
false
1800
89.9
D
4604
D
Common Stock
2014-12-29
4
S
false
2844
91.34
D
1760
D
Common Stock
2014-12-29
4
S
false
1156
92.1
D
604
D
Common Stock
2014-12-29
4
S
false
300
93.04
D
304
D
Stock Option (Right to Buy)
1.7
2014-12-29
4
M
false
1100
0
D
2021-05-25
Common Stock
1100
838
D
Stock Option (Right to Buy)
23
2014-12-29
4
M
false
5000
0
D
2021-12-20
Common Stock
5000
5000
D
The stock option exercise and sale of shares of the Company's common stock (the "Shares") reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 3, 2014.
The Stock Option granted the reporting person an option to purchase 6,188 Shares. 25% of such Shares vested and became exercisable on 05/25/2012, and 1/36 of the remainder of such Shares vest and become exercisable monthly thereafter.
The Stock Option granted the reporting person an option to purchase 15,000 Shares. 25% of such Shares vested and became exercisable on 12/20/2012, and 1/36 of the remainder of such Shares vest and become exercisable monthly thereafter.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $89.65 to $90.47. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $90.82 to $91.84. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $91.88 to $92.18. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $92.92 to $93.20. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
/s/ Chris Heberlig
2014-12-30